Comparison

PFI-2 (hydrochloride) European Partner

Item no. HY-18627A-10mg
Manufacturer MedChem Express
CASRN 1627607-87-7
Amount 10 mg
Quantity options 10 mM/1 mL 10 mg 1 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.48
Citations [1]Yuzhen Niu, et al. Revealing inhibition difference between PFI-2 enantiomers against SETD7 by molecular dynamics simulations, binding free energy calculations and unbinding pathway analysis. Sci Rep. 2017 Apr 18;7:46547.|[2]Benquan Liu, et al. Pharmacological inhibition of SETD7 by PFI-2 attenuates renal fibrosis following folic acid and obstruction injury. Eur J Pharmacol. 2021 Jun 15;901:174097.
Diabetes. 2025 Feb 27:db240997.|Int J Mol Med. 2021 Dec;48(6):210.|Mol Carcinog. 2023 May 5.|Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):2961-2966. |Research Square Print. September 20th, 2022.|Acta Pharmacol Sin. 2021 Apr 13.|Biochem Pharmacol. 2023 Dec 2:115964.|Med Oncol. 2023 Apr 12;40(5):146.|Patent. US20180263995A1.|Sci Adv. 2023 May 26;9(21):eade4186.|Sci Total Environ. 2022 Dec 5;861:160682.
Smiles O=S(C1=CC2=C(CNCC2)C(F)=C1)(N[C@H](CC3=CC=CC(C(F)(F)F)=C3)C(N4CCCC4)=O)=O.[H]Cl
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias (R)-PFI-2 hydrochloride
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
Histone Methyltransferase
Shipping Temperature
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Molecular Weight
535.98
Product Description
PFI-2 ((R)-PFI-2 hydrochloride) hydrochloride is a potent and selective SET domain containing lysine methyltransferase 7 (SETD7) inhibitor. (R)-PFI-2 shows high inhibiting activity with IC50 value of 2.0  nM and (S)-PFI-2 shows inhibiting activity with IC50  value of 1.0  μM. PFI-2 hydrochloride can be used for the research of chronic kidney disease and inflammation response in the development of renal fibrosis[1][2].
Manufacturer - Research Area
Cancer; Infection; Inflammation/Immunology
Solubility
DMSO: ≥ 32 mg/mL|H2O: 5.56 mg/mL (ultrasonic)
Manufacturer - Pathway
Epigenetics
Isoform
SETD7/KMT7
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close